
Jon E. Angell
Examiner (ID: 3741, Phone: (571)272-0756 , Office: P/1674 )
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1635, 1637, 1674 |
| Total Applications | 1431 |
| Issued Applications | 721 |
| Pending Applications | 199 |
| Abandoned Applications | 530 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 111944
[patent_doc_number] => 07718627
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-18
[patent_title] => 'Vector'
[patent_app_type] => utility
[patent_app_number] => 11/380188
[patent_app_country] => US
[patent_app_date] => 2006-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 21438
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/718/07718627.pdf
[firstpage_image] =>[orig_patent_app_number] => 11380188
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/380188 | Vector | Apr 24, 2006 | Issued |
Array
(
[id] => 5732741
[patent_doc_number] => 20060257858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Methods and compositions for introducing biopolymers into cells'
[patent_app_type] => utility
[patent_app_number] => 11/396287
[patent_app_country] => US
[patent_app_date] => 2006-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 27625
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20060257858.pdf
[firstpage_image] =>[orig_patent_app_number] => 11396287
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/396287 | Methods and compositions for introducing biopolymers into cells | Mar 30, 2006 | Abandoned |
Array
(
[id] => 7691477
[patent_doc_number] => 20070232556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-04
[patent_title] => 'Methods and compositions for the treatment of neurological diseases and disorders'
[patent_app_type] => utility
[patent_app_number] => 11/396212
[patent_app_country] => US
[patent_app_date] => 2006-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 38359
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20070232556.pdf
[firstpage_image] =>[orig_patent_app_number] => 11396212
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/396212 | Methods and compositions for the treatment of neurological diseases and disorders | Mar 30, 2006 | Abandoned |
Array
(
[id] => 5754628
[patent_doc_number] => 20060223777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-05
[patent_title] => 'Highly functional short hairpin RNA'
[patent_app_type] => utility
[patent_app_number] => 11/390829
[patent_app_country] => US
[patent_app_date] => 2006-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 20296
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20060223777.pdf
[firstpage_image] =>[orig_patent_app_number] => 11390829
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/390829 | Highly functional short hairpin RNA | Mar 27, 2006 | Abandoned |
Array
(
[id] => 4853141
[patent_doc_number] => 20080318884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-25
[patent_title] => 'Methods for Altering Gene Expression and Methods of Treatment Utilizing Same'
[patent_app_type] => utility
[patent_app_number] => 11/909691
[patent_app_country] => US
[patent_app_date] => 2006-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16418
[patent_no_of_claims] => 122
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20080318884.pdf
[firstpage_image] =>[orig_patent_app_number] => 11909691
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/909691 | Methods for Altering Gene Expression and Methods of Treatment Utilizing Same | Mar 26, 2006 | Abandoned |
Array
(
[id] => 9951157
[patent_doc_number] => 08999943
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-07
[patent_title] => 'Antigene oligomers inhibit transcription'
[patent_app_type] => utility
[patent_app_number] => 11/376483
[patent_app_country] => US
[patent_app_date] => 2006-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10746
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11376483
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/376483 | Antigene oligomers inhibit transcription | Mar 13, 2006 | Issued |
Array
(
[id] => 5694723
[patent_doc_number] => 20060154870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-13
[patent_title] => 'Method for prevention or treatment of diseases or disorders related to excessive formation of vascular tissue or blood vessels'
[patent_app_type] => utility
[patent_app_number] => 11/372212
[patent_app_country] => US
[patent_app_date] => 2006-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7787
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20060154870.pdf
[firstpage_image] =>[orig_patent_app_number] => 11372212
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/372212 | Method for prevention or treatment of diseases or disorders related to excessive formation of vascular tissue or blood vessels | Mar 9, 2006 | Abandoned |
Array
(
[id] => 5405892
[patent_doc_number] => 20090241207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'Expression of heterologous genes according to a targeted expression profile'
[patent_app_type] => utility
[patent_app_number] => 11/364042
[patent_app_country] => US
[patent_app_date] => 2006-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8836
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20090241207.pdf
[firstpage_image] =>[orig_patent_app_number] => 11364042
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/364042 | Expression of heterologous genes according to a targeted expression profile | Feb 27, 2006 | Abandoned |
Array
(
[id] => 4866317
[patent_doc_number] => 20080145376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-19
[patent_title] => 'Vectors And Methods For Genetic Immunization'
[patent_app_type] => utility
[patent_app_number] => 11/814311
[patent_app_country] => US
[patent_app_date] => 2006-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 21494
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0145/20080145376.pdf
[firstpage_image] =>[orig_patent_app_number] => 11814311
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/814311 | Vectors and methods for genetic immunization | Jan 19, 2006 | Issued |
Array
(
[id] => 5733445
[patent_doc_number] => 20060258562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Methods and pharmaceutical compositions for healing wounds'
[patent_app_type] => utility
[patent_app_number] => 11/332774
[patent_app_country] => US
[patent_app_date] => 2006-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 34839
[patent_no_of_claims] => 98
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20060258562.pdf
[firstpage_image] =>[orig_patent_app_number] => 11332774
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/332774 | Methods and pharmaceutical compositions for healing wounds | Jan 16, 2006 | Abandoned |
Array
(
[id] => 5409528
[patent_doc_number] => 20090123426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-14
[patent_title] => 'Compositions for Bacterial Mediated Gene Silencing and Methods of Using the Same'
[patent_app_type] => utility
[patent_app_number] => 11/793429
[patent_app_country] => US
[patent_app_date] => 2005-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 17635
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20090123426.pdf
[firstpage_image] =>[orig_patent_app_number] => 11793429
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/793429 | Compositions for Bacterial Mediated Gene Silencing and Methods of Using the Same | Dec 15, 2005 | Abandoned |
Array
(
[id] => 5859809
[patent_doc_number] => 20060229268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-12
[patent_title] => 'Small interference RNA (siRNA) molecules for modulating superoxide dismutase (SOD)'
[patent_app_type] => utility
[patent_app_number] => 11/303452
[patent_app_country] => US
[patent_app_date] => 2005-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11784
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20060229268.pdf
[firstpage_image] =>[orig_patent_app_number] => 11303452
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/303452 | Small interference RNA (siRNA) molecules for modulating superoxide dismutase (SOD) | Dec 15, 2005 | Abandoned |
Array
(
[id] => 5306280
[patent_doc_number] => 20090300776
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'COMPOSITIONS FOR PREVENTING, REDUCING OR TREATING KERATINOCYTE-MEDIATED INFLAMMATION'
[patent_app_type] => utility
[patent_app_number] => 11/721763
[patent_app_country] => US
[patent_app_date] => 2005-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11735
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0300/20090300776.pdf
[firstpage_image] =>[orig_patent_app_number] => 11721763
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/721763 | COMPOSITIONS FOR PREVENTING, REDUCING OR TREATING KERATINOCYTE-MEDIATED INFLAMMATION | Dec 14, 2005 | Abandoned |
Array
(
[id] => 5304258
[patent_doc_number] => 20090298910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'REGULATION OF EPIGENETIC CONTROL OF GENE EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 11/721326
[patent_app_country] => US
[patent_app_date] => 2005-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47996
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20090298910.pdf
[firstpage_image] =>[orig_patent_app_number] => 11721326
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/721326 | Regulation of epigenetic control of gene expression | Dec 11, 2005 | Issued |
Array
(
[id] => 4624323
[patent_doc_number] => 08003619
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-23
[patent_title] => 'Method of stimulating an immune response and inhibiting expression of a gene using an oligonucleotide'
[patent_app_type] => utility
[patent_app_number] => 11/298850
[patent_app_country] => US
[patent_app_date] => 2005-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 6
[patent_no_of_words] => 24514
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/003/08003619.pdf
[firstpage_image] =>[orig_patent_app_number] => 11298850
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/298850 | Method of stimulating an immune response and inhibiting expression of a gene using an oligonucleotide | Dec 8, 2005 | Issued |
Array
(
[id] => 5063039
[patent_doc_number] => 20070224679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-27
[patent_title] => 'Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA'
[patent_app_type] => utility
[patent_app_number] => 11/291390
[patent_app_country] => US
[patent_app_date] => 2005-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 17419
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20070224679.pdf
[firstpage_image] =>[orig_patent_app_number] => 11291390
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/291390 | Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA | Nov 30, 2005 | Issued |
Array
(
[id] => 5672975
[patent_doc_number] => 20060178330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Use of antisense oligonucleotides or siRNA to suppress expression of eIF-5A1'
[patent_app_type] => utility
[patent_app_number] => 11/287460
[patent_app_country] => US
[patent_app_date] => 2005-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 101
[patent_figures_cnt] => 101
[patent_no_of_words] => 33736
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20060178330.pdf
[firstpage_image] =>[orig_patent_app_number] => 11287460
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/287460 | Use of antisense oligonucleotides or siRNA to suppress expression of eIF-5A1 | Nov 27, 2005 | Issued |
Array
(
[id] => 5613534
[patent_doc_number] => 20060115462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-01
[patent_title] => 'Direct DNA delivery to bone cells'
[patent_app_type] => utility
[patent_app_number] => 11/286719
[patent_app_country] => US
[patent_app_date] => 2005-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6381
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20060115462.pdf
[firstpage_image] =>[orig_patent_app_number] => 11286719
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/286719 | Direct DNA delivery to bone cells | Nov 22, 2005 | Abandoned |
Array
(
[id] => 5844366
[patent_doc_number] => 20060122140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'In Vitro and in vivo silencing of human c-myc oncogene expression by poly-DNP-RNA'
[patent_app_type] => utility
[patent_app_number] => 11/284693
[patent_app_country] => US
[patent_app_date] => 2005-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7713
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20060122140.pdf
[firstpage_image] =>[orig_patent_app_number] => 11284693
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/284693 | In Vitro and in vivo silencing of human c-myc oncogene expression by poly-DNP-RNA | Nov 21, 2005 | Abandoned |
Array
(
[id] => 9662311
[patent_doc_number] => 08809287
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-19
[patent_title] => 'Compositions and methods for altering Wnt autocrine signaling'
[patent_app_type] => utility
[patent_app_number] => 11/719327
[patent_app_country] => US
[patent_app_date] => 2005-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 23
[patent_no_of_words] => 17056
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11719327
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/719327 | Compositions and methods for altering Wnt autocrine signaling | Nov 14, 2005 | Issued |